Int J Res Pharma.2012;3:96-99
This overview reports BPC-157s definition, proposed biological mechanisms, research status, and regulatory position within sports and military settings, providing concise conclusions followed by supporting context
A 2025 systematic review (Vasireddi et al., SAGE Journals) confirmed this preclinical support but documented the absence of randomized controlled trials in humans
Indications: FDA : Topical anesthesia of the upper respiratory tract (due to its combined vasoconstrictor & local anesthetic properties) Off Label : Use in Emergency Department as one ingredient in a topical anesthetic solution called TAC (containing: Tetracaine, Adrenaline & Cocaine) that is applied to a wound prior to cleaning & suturing Contraindications: Hypersensitivity to ester anesthetics Side Effects: Acute signs of systemic toxicity include can include multiple signs of both CV & CNS stimulation: tachycardia hypertension hyperthermia mydriasis seizures cardiac arrhythmias (multiple contributing variables: Na & K channel block, possible coronary vasoconstriction) Acute effects associated with cocaine abuse
Preclinical combination data exists
Clinical response is enhanced when supported by a whole-food diet, adequate hydration, stress management, and quality sleep all of which directly influence gut barrier function and mucosal repair